AstraZeneca (Spain)

AstraZeneca (Spain)

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for AstraZeneca (Spain), Spain, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

63%


Total
Publications

664


Total Open
Publications

418


Total
Citations

15K


Open Access
Percentage

63%


Total
Publications

664


Total Open
Publications

418


Total
Citations

15K

Wikipedia

Website

download

Breakdown

25% 30% 8% 37%

Publisher Open

25%

Both

30%

Other Platform Open

8%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

38%OA Journal

OA Journal 38%

140

Hybrid 36%

133

No Guarantees 26%

93

Other Platform Open

Domain 64%

160

Institution 42%

105

Other Internet 23%

57

Public 12%

29

Preprint 3%

8

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
159
Europe PMC
Domain
78
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
25
Semantic Scholar
Public
21
Aberdeen University - Aberdeen University Research Archive
Institution
17
lshtm.ac.uk OAI-PMH Repository
Institution
14
Ghent University - Ghent University Academic Bibliography
Institution
14
Queen's University Belfast - Research Portal
Institution
13
Conselleria de Salut i Consum del Govern de les Illes Balears - Docusalut
Other Internet
10
Universitat de Barcelona - Dipòsit Digital de la Universitat de Barcelona
Institution
9
1 / 10

Data updated 8 December 2024

Share

Share

Share